198 related articles for article (PubMed ID: 29368147)
21. Ellipticine and benzo(a)pyrene increase their own metabolic activation via modulation of expression and enzymatic activity of cytochromes P450 1A1 and 1A2.
Aimová D; Poljaková J; Kotrbová V; Moserová M; Frei E; Arlt VM; Stiborová M
Interdiscip Toxicol; 2008 Sep; 1(2):160-8. PubMed ID: 21218107
[TBL] [Abstract][Full Text] [Related]
22. The impact of individual cytochrome P450 enzymes on oxidative metabolism of benzo[a]pyrene in human livers.
Šulc M; Indra R; Moserová M; Schmeiser HH; Frei E; Arlt VM; Stiborová M
Environ Mol Mutagen; 2016 Apr; 57(3):229-35. PubMed ID: 26919089
[TBL] [Abstract][Full Text] [Related]
23. Effect of Cytochrome P450 Reductase Deficiency on 2-Amino-9H-pyrido[2,3-b]indole Metabolism and DNA Adduct Formation in Liver and Extrahepatic Tissues of Mice.
Turesky RJ; Konorev D; Fan X; Tang Y; Yao L; Ding X; Xie F; Zhu Y; Zhang QY
Chem Res Toxicol; 2015 Dec; 28(12):2400-10. PubMed ID: 26583703
[TBL] [Abstract][Full Text] [Related]
24. Effect of dietary restriction on benzo[a]pyrene (BaP) metabolic activation and pulmonary BaP-DNA adduct formation in mouse.
Chen W; Zhou Y; Nichols J; Chung KT; Hart RW; Chou MW
Drug Chem Toxicol; 1996; 19(1-2):21-39. PubMed ID: 8804551
[TBL] [Abstract][Full Text] [Related]
25. Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer.
Stiborová M; Frei E; Hodek P; Wiessler M; Schmeiser HH
Int J Cancer; 2005 Jan; 113(2):189-97. PubMed ID: 15386410
[TBL] [Abstract][Full Text] [Related]
26. Benzo[a]pyrene metabolism and DNA adduct formation mediated by English sole liver enzymes.
Nishimoto M; Varanasi U
Biochem Pharmacol; 1985 Jan; 34(2):263-8. PubMed ID: 4038451
[TBL] [Abstract][Full Text] [Related]
27. Dietary restriction modulated carcinogen-DNA adduct formation and the carcinogen-induced DNA strand breaks.
Chou MW; Chen W; Mikhailova MV; Nichols J; Weis C; Jackson CD; Hart RW; Chung KT
Toxicol Lett; 1997 Jun; 92(1):21-30. PubMed ID: 9242354
[TBL] [Abstract][Full Text] [Related]
28. The role of small-intestinal P450 enzymes in protection against systemic exposure of orally administered benzo[a]pyrene.
Fang C; Zhang QY
J Pharmacol Exp Ther; 2010 Jul; 334(1):156-63. PubMed ID: 20400470
[TBL] [Abstract][Full Text] [Related]
29. Cytochrome P450 system expression and DNA adduct formation in the liver of Zacco platypus following waterborne benzo(a)pyrene exposure: implications for biomarker determination.
Lee JW; Kim YH; Yoon S; Lee SK
Environ Toxicol; 2014 Sep; 29(9):1032-42. PubMed ID: 23192953
[TBL] [Abstract][Full Text] [Related]
30. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
31. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.
Ploch SA; King LC; Kohan MJ; Di Giulio RT
Toxicol Appl Pharmacol; 1998 Mar; 149(1):90-8. PubMed ID: 9512731
[TBL] [Abstract][Full Text] [Related]
32. Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2.
Stiborová M; Frei E; Wiessler M; Schmeiser HH
Chem Res Toxicol; 2001 Aug; 14(8):1128-37. PubMed ID: 11511187
[TBL] [Abstract][Full Text] [Related]
33. Benzo[
Dračínská H; Indra R; Jelínková S; Černá V; Arlt VM; Stiborová M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360828
[TBL] [Abstract][Full Text] [Related]
34. Oxidation of carcinogenic benzo[a]pyrene by human and rat cytochrome P450 1A1 and its influencing by cytochrome b5 - a comparative study.
Indra R; Moserova M; Sulc M; Frei E; Stiborova M
Neuro Endocrinol Lett; 2013; 34 Suppl 2():55-63. PubMed ID: 24362093
[TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro metabolism of benzo[a]pyrene by recombinant zebrafish CYP1A and liver microsomes from beta-naphthoflavone-treated rainbow trout.
Miranda CL; Chung WG; Wang-Buhler JL; Musafia-Jeknic T; Baird WM; Buhler DR
Aquat Toxicol; 2006 Nov; 80(2):101-8. PubMed ID: 16963132
[TBL] [Abstract][Full Text] [Related]
36. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
37. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase.
Joseph P; Jaiswal AK
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8413-7. PubMed ID: 8078896
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody to rat liver cytochrome P450 IIC11 strongly and regiospecifically inhibits constitutive benzo[a]pyrene metabolism and DNA binding.
Todorovic R; Devanesan PD; Cavalieri EL; Rogan EG; Park SS; Gelboin HV
Mol Carcinog; 1991; 4(4):308-14. PubMed ID: 1872951
[TBL] [Abstract][Full Text] [Related]
39. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
[TBL] [Abstract][Full Text] [Related]
40. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
